Innovative Fusion of Speed and Accuracy

High-sensitivity, high-throughput, and fast molecular
diagnostics on open RT-PCR instruments.

RNA STAR Complete

SARS-CoV-2 RNA STAR Complete offers high sensitivity, high throughput, and fast direct amplification within 20 minutes to support core lab, school, workplace, travel, and event testing.
  • Based on in silico analysis we confirm detection of all known circulating variants including Omicron, Omicron B.2 and Delta
  • Authorized for the screening of asymptomatic individuals
  • Validated on multiple open 96- and 384-well RT-PCR instruments


SARS-CoV-2 RNA STAR is a rapid nucleic acid amplification assay.

LumiraDx SARS-CoV-2 RNA STAR qualitatively detects RNA from SARS-CoV-2 in upper respiratory specimens. LumiraDx SARS-CoV-2 RNA STAR reagents are designed to reduce the amplification steps of the PCR process.

SARS-CoV-2 RNA STAR and SARS-CoV-2 RNA STAR Complete have not been FDA cleared or approved but have been authorized by FDA for emergency use under an EUA for use by authorized laboratories. SARS-CoV-2 RNA STAR and SARS-CoV-2 RNA STAR Complete have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of SARS-CoV-2 RNA STAR and SARS-CoV-2 RNA STAR Complete is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner

Users should refer to the LumiraDx SARS-CoV-2 RNA STAR or the SARS-CoV-2 RNA STAR Complete Instructions for Use posted on the FDA website for all IVD products used under Emergency Use Authorization,

In Vitro Diagnostics EUAs - Molecular Diagnostic Tests for SARS-CoV-2 | FDA


Supporting healthier lives, for individuals, communities and wider society

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.

Be Informed